LATEST NEWS FROM LAMASSU BIOTECH

05/16/2025

LAMASSU BIOTECH COLLABORATES WITH THE OHIO STATE UNIVERSITY TO STUDY NEW THERAPY FOR MAN AND MAN’S BEST FRIEND

Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man’s Best Friend (CLEVELAND, OH) – Man’s best friend may soon benefit from a new treatment,...
READ THE ARTICLE
02/07/2025

LAMASSU BIOTECH SET TO ATTEND LEAP 2025

International Conference in Saudi Arabia An Opportunity to Highlight Synergy BetweenTechnology and Medicine (CLEVELAND, OH) — Lamassu Biotech, a pioneering biotechnology company dedicated to developing breakthrough treatments for challenging diseases,...
READ THE ARTICLE
05/16/2024

LAMASSU BIOTECH WELCOMES DR. SAMIR JOHNA AS A CLINICAL ADVISOR

Esteemed Surgeon and Researcher Brings Decades of Experience to Drive Innovation in Biopharmaceuticals (CLEVELAND, OH) - Lamassu BioTech is thrilled to announce the addition of Dr. Samir Johna, MD, MACM,...
READ THE ARTICLE
05/16/2024

INNOVATIVE CANCER RESEARCH FIRM LAMASSU BIOTECH ANNOUNCES NEW CORPORATE OFFICES IN CLEVELAND

Lamassu Recently Earned Prestigious NIH Grant and Won FDA Approval to Trial Potentially Transformative Treatment for Metastatic Cancers (CLEVELAND, OH) – One of the pharmaceutical industry’s most leading-edge companies, Lamassu...
READ THE ARTICLE
04/11/2024

POSSIBLE NEW HOPE FOR METASTATIC CANCER PATIENTS: FDA GRATS APPROVAL FOR CLINICAL TRIALS OF LAMASSU’S GROUNDBREAKING CANCER TREATMENT PROTOCOL

(CLEVELAND, OH) - More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat locally advanced metastatic p53 wild-type tumors...
READ THE ARTICLE
03/12/2024

LAMASSU AWARDED NIH GRANT FOR BREAKTHROUGH CANCER TREATMENT

Promising New Therapy for Sarcomas Could Reduce Reliance on Surgery, Chemotherapy and other Invasive and Toxic Treatments (CLEVELAND, OH) - Lamassu Bio Inc., a cutting-edge biotech company dedicated to innovative...
READ THE ARTICLE
04/20/2021

LAMASSU PHARMA ANNOUNCES DEVELOPMENT OF NEW PANCREATITIS TREATMENT THAT ADVANCES UNDERSTANDING OF FATTY ACIDS’ ROLE IN COVID-19

(DURHAM, NC) - Despite being known as "good" fat, excess unsaturated fatty acids may prove deadly for patients who develop, pancreatitis, COVID-19 and other acute illnesses. A new Mayo Clinic study...
READ THE ARTICLE

MEDIA COVERAGE

LAMASSU BIOTECH IN THE NEWS

See recent coverage about Lamassu Biotech's innovative cancer research and treatment.

Read More